Implementation of Sole Sensor Technology in Neurological Rehabilitation to reveal Inter- and Intraindividual Differences in Temporospatial Gait Patterns of Neurological Patients

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00031818

Enrollment

Registered

2023-05-08

Start date

2023-04-15

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

I60-I69 G35

Interventions

Group 1: Observation period: 04/03/2023 - 06/30/2023. A three-month duocentric implementation study will be conducted to evaluate the use of sole sensor technology as a basic assessment in neurologica

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Main diagnosis stroke or multiple sclerosis. Ability to walk (Functional Ambulation Categories (FAC) = 3). Multiple Sclerosis Patients: Expanded Disability Status Scale (EDSS) = 6.

Exclusion criteria

Exclusion criteria: ability to walk (FAC 6

Design outcomes

Primary

Measure	Time frame
The aim is to evaluate the use of sole sensor technology as a basic assessment tool in neurological rehabilitation to detect individual differences in a patient's gait pattern or between patient groups. The pilot study focuses on evaluating the accessibility, usability, and acceptability of the product in the clinical setting. Another important aspect of the study is the translation of the gait analysis results into clinical applications. Measure accessibility, usability, and acceptance of the product, as well as psychological factors (e.g., interest, curiosity, and anxiety) among therapists/clinical staff, after completion of patient measurements in the implementation study, using the Technology Usage Inventory (TUI) questionnaire. Measurement of the patient's assessment of the usability of the sole sensor system, after T3, using the System Usability Scale (SUS) questionnaire.	—

Measure

Time frame

The aim is to evaluate the use of sole sensor technology as a basic assessment tool in neurological rehabilitation to detect individual differences in a patient's gait pattern or between patient groups. The pilot study focuses on evaluating the accessibility, usability, and acceptability of the product in the clinical setting. Another important aspect of the study is the translation of the gait analysis results into clinical applications. Measure accessibility, usability, and acceptance of the product, as well as psychological factors (e.g., interest, curiosity, and anxiety) among therapists/clinical staff, after completion of patient measurements in the implementation study, using the Technology Usage Inventory (TUI) questionnaire. Measurement of the patient's assessment of the usability of the sole sensor system, after T3, using the System Usability Scale (SUS) questionnaire.

—

Secondary

Measure	Time frame
Evaluation of gait assessment at T1, T2, T3 with the help of sole sensor technology (intraindividual differences) Analysis of differences in gait pattern between stroke and MS patients with the help of sole sensor technology (interindividual differences) Influence of different footwear on gait analysis, comparison of the two T1 measurements (with own footwear and with Stappone shoes), using sole sensor technology	—

Measure

Time frame

Evaluation of gait assessment at T1, T2, T3 with the help of sole sensor technology (intraindividual differences) Analysis of differences in gait pattern between stroke and MS patients with the help of sole sensor technology (interindividual differences) Influence of different footwear on gait analysis, comparison of the two T1 measurements (with own footwear and with Stappone shoes), using sole sensor technology

—

Countries

Germany

Contacts

Public ContactMandy;Ines Bade;Guse

MEDIAN Klinik NRZ Magdeburg;MEDIAN Klinik NRZ Magdeburg

mandy.bade1@median-kliniken.de;Ines.GuseM.A@median-kliniken.de+49 391 610 1160;Tel: 0391/610-1160

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026